IP Library Assignment 036268/0626
Patent Assignment
Reel/Frame 036268/0626

Nunc Pro Tunc Assignment

Recorded: 2015-08-06 Pages: 6
Assignor
CUBIST PHARMACEUTICALS LLC
Executed: 2015-08-05
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties (39)
Aminoacyl Adenylate Mimics as Novel Antimicrobial and Antiparasitic Agents
Patent: 5,726,195 →
Application: 08/683,809 →
Methods for Generating and Screening Novel Metabolic Pathways
Patent: 5,783,431 →
Application: 08/738,944 →
Enterococcal Aminoacyl-Trna Synthetase Proteins, Nucleic Acids and Strains Comprising Same
Patent: 6,221,640 →
Application: 08/855,910 →
Methods for Generating and Screening Novel Metabolic Pathways
Patent: 6,242,211 →
Application: 09/263,352 →
Novel Lipopeptides as Antibacterial Agents
Patent: 7,408,025 →
Application: 09/737,908 →
Publication: US 2004/0067878
Novel Lipopeptides as Antibacterial Agents
Patent: 6,911,525 →
Application: 09/738,742 →
Publication: US 2002/0025924
Novel Lipopeptides as Antibacterial Agents
Patent: 6,794,490 →
Application: 09/739,535 →
Publication: US 2002/0058785
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials
Patent: 7,527,807 →
Application: 09/888,114 →
Publication: US 2003/0039956
Novel Lipopeptides as Antibacterial Agents
Patent: 7,335,725 →
Application: 11/121,851 →
Publication: US 2005/0203006
Therapeutic Compositions
Patent: 8,968,781 →
Application: 11/912,833 →
Publication: US 2008/0213366
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials
Patent: 8,303,989 →
Application: 12/425,099 →
Publication: US 2009/0264340
Novel Antibacterial Agents for the Treatment of Gram Positive Infections
Patent: 8,507,647 →
Application: 12/641,465 →
Publication: US 2010/0184649
CB-183,315 Compositions and Related Methods
Application: 13/481,009 →
Publication: US 2013/0109633
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,962,843 →
Application: 13/853,327 →
Publication: US 2013/0296290
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,933,232 →
Application: 13/853,439 →
Publication: US 2013/0296291
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,933,233 →
Application: 13/853,443 →
Publication: US 2013/0303504
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,940,897 →
Application: 13/853,452 →
Publication: US 2013/0296292
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,962,844 →
Application: 13/853,460 →
Publication: US 2013/0296293
Isoxazole Beta-Lactamase Inhibitors
Patent: 8,927,724 →
Application: 13/853,498 →
Publication: US 2013/0345190
1,2,4-Oxadiazole and 1,2,4-Thiadiazole Beta-Lactamase Inhibitors
Patent: 8,916,709 →
Application: 13/853,506 →
Publication: US 2013/0289012
Beta-Lactamase Inhibitors
Patent: 8,969,570 →
Application: 13/853,562 →
Publication: US 2013/0296555
Cephalosporin Compound
Patent: 8,809,314 →
Application: 14/020,230 →
Crystalline Form of a Beta-Lactamase Inhibitor
Patent: 9,120,795 →
Application: 14/212,993 →
Publication: US 2014/0275001
Beta-Lactamase Inhibitors
Patent: 9,108,966 →
Application: 14/216,476 →
Publication: US 2014/0316133
Isoxazole Beta-Lactamase Inhibitors
Application: 14/260,184 →
Publication: US 2014/0323459
Cephalosporin Compound
Application: 14/333,966 →
Publication: US 2015/0025053
Crystalline Form of a Beta-Lactamase Inhibitor
Application: 14/504,786 →
Publication: US 2015/0111864
B-Lactamase Inhibitor Picoline Salt
Patent: 9,120,796 →
Application: 14/504,860 →
Publication: US 2015/0094472
Beta-Lactamase Inhibitors
Application: 14/505,432 →
Publication: US 2015/0038478
Isoxazole Beta-Lactamase Inhibitors
Application: 14/505,436 →
Publication: US 2015/0038479
Isoxazole Beta-Lactamase Inhibitors
Application: 14/505,438 →
Publication: US 2015/0038482
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Application: 14/505,442 →
Publication: US 2015/0031659
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Beta-Lactamase Inhibitors
Application: 14/505,445 →
Publication: US 2015/0031665
1,2,4-Oxadiazole and 1,2,4-Thiadiazole Beta-Lactamase Inhibitors
Application: 14/505,450 →
Publication: US 2015/0031660
1,2,4-Oxadiazole and 1,2,4-Thiadiazole Beta-Lactamase Inhibitors
Application: 14/505,453 →
Publication: US 2015/0031666
Therapeutic Compositions
Application: 14/592,526 →
Publication: US 2015/0165029
Method for Screening Lyophilized Parenteral Formulations
Application: 14/701,229 →
Publication: US 2015/0316568
Method for Screening Lyophilized Parenteral Formulations
Application: 61/986,537 →
CCR9 Antagonist Compounds
Application: 62/031,889 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Nov 20, 2012
From: CUBIST PHARMACEUTICALS, INC.; ADOLOR CORPORATION; CALIXA THERAPEUTICS, INC.; CUBIST PHARMACEUTICALS HOLDINGS, INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 029339/0669 →
Assignment of Assignor's Interest Jul 19, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 030839/0607 →
Assignment of Assignor's Interest Jul 19, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 030839/0270 →
Assignment of Assignor's Interest Jul 19, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 030839/0461 →
Assignment of Assignor's Interest Jul 19, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 030839/0513 →
Assignment of Assignor's Interest Jul 19, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 030839/0569 →
Assignment of Assignor's Interest Aug 28, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031097/0746 →
Corrective Assignment to Correct the Property Numbers 61/618,131 Previously Recorded on Reel 030839 Frame 0461. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 032147/0319 →
Corrective Assignment to Correct the Property Numbers Previously Recorded on Reel 030839 Frame 0607. Assignor(S) Hereby Confirms Assignment the Removal of Application Number 61/618,131 Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031947/0759 →
Corrective Assignment to Correct the Property Numbers 61/618,131 Recorded on Reel 030839 Frame 0607. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031786/0894 →
Corrective Assignment to Correct the Property Numbers 61/618,127 Previously Recorded on Reel 031097 Frame 0746. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031799/0019 →
Corrective Assignment to Correct the Property Number 61/618,131 Recorded on Reel 030839 Frame 0569. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031865/0356 →
Corrective Assignment to Correct the Property Numbers 61/618,131 Recorded on Reel 030839 Frame 0513. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031872/0853 →
Corrective Assignment to Correct the Property Numbers 61/618,131 Recorded on Reel 030839 Frame 0270. Assignor(S) Hereby Confirms the Assignment. Nov 14, 2013
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031873/0141 →
Assignment of Assignor's Interest Jan 16, 2014
From: GU, YU GUI; HE, YONG; YIN, NING; ALEXANDER, DYLAN C.
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 031983/0695 →
Assignment of Assignor's Interest Nov 6, 2014
From: BABER, JON CHRISTIAN; WAN, DONGPENG
To: CUBIST PHARMACEUTICALS INC.,
Reel/Frame 034118/0772 →
Assignment of Assignor's Interest Nov 6, 2014
From: WAN, DONGPENG
To: CUBIST PHARMACEUTICALS, INC.,
Reel/Frame 034118/0681 →
Assignment of Assignor's Interest Jul 2, 2015
From: CUBIST PHARMACEUTICALS, INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 035969/0613 →
Release of Security Interest Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: CALIXA THERAPEUTICS, INC.; ADOLOR CORPORATION; CUBIST PHARMACEUTICALS, INC.
Reel/Frame 036180/0070 →
Change of Name Aug 5, 2015
From: CUBIST PHARMACEUTICALS, INC.
To: CUBIST PHARMACEUTICALS LLC
Reel/Frame 036283/0189 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →